Droia is a specialist investor, exclusively focused on the development of oncology and genetic disease therapies.
Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in newly founded or early-stage platform companies that apply novel science and innovative technologies to bring first-in-class drug candidates to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patient lives.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 11, 2020
PACT Pharma
|
Series C | $75M | Biotechnology | — |
Nov 13, 2017
Arcus Biosciences
|
Series C | $107M | Biotechnology | — |
Sep 1, 2016
Arcus Biosciences
|
Series B | $70M | Biotechnology | — |